BioNexus Gene Lab Corp (BGLC) Q4 2024 Earnings
BGLC·Reported April 15, 2025·Before market open
BioNexus Gene Lab Corp reported Q4 2024 revenue of $2.5M. Diluted EPS came in at $-0.19.
Revenue
$2.5M
Diluted EPS
$-0.19
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about BioNexus Gene Lab Corp's Q4 2024 earnings report.
BioNexus Gene Lab Corp (BGLC) reported Q4 2024 earnings on April 15, 2025 before market open.
BioNexus Gene Lab Corp reported revenue of $2.5M and diluted EPS of $-0.19 for Q4 2024.